Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Thromb Haemost. 2019 Jul 23;17(10):1683–1693. doi: 10.1111/jth.14543

Table 2.

Toll-like receptor deficiency impacts plasma procoagulants and IL-6 at 24 hours after sham or CLP surgery.

Strain Intervention TF Fibrinogen PAI-1 Il-6

(pg/mL) (mg/mL) (pg/mL) (pg/mL)
WT Sham 22.9±0.99 3.08±0.13 47.6±26.3 58.6±14.1
CLP 112.6±20.7*** 3.53±0.31 39,001±10828** 142,890±24442****

 

TLR7−/− Sham 23.4±0 2.91±0.12 28.1±12.29 118±4.25
CLP 24.7±5.7Δ 4.41±0.62* 23,571±7563** 12,249±3391**/ΔΔΔ

TLR2−/− Sham 23.4±0 3.05±0.18 9.38±0 15.6±0
CLP 39.3±5.97* 4.04±0.23** 52,027±12927** 4,734±3239ΔΔ

MyD88−/− Sham 23.4±25 2.22±0.27 9.38±0 51.3±16.6
CLP 25±4.52Δ 4.54±0.39*** 27,206±8099* 6,814±2009*/ΔΔΔ

Trif−/− Sham 23.4±0 2.72±0.12 9.38±0 16.7±5.95
CLP 68.7±35.3 5.88±0.45*** 46,040±16549* 64,686±32823

 

TLR3−/− Sham 23.4±0 2.93±0.15 9.38±0 7.69±3.24
CLP 92.8±33.8 2.36±0.47 26,114±6338** 39,778±16656

TLR4−/− Sham 23.4±0 3.26±0.21 9.38±0 66.4±23.2
CLP 113.9±30.9* 2.12±0.60 44,391±16723* 109,463±34771**

* or # represents significant difference between sham and CLP mice within the same strain.

Δ

represents significant difference between WT CLP and TLR−/− CLP mice.

#

P = 0.05

*

P < 0.05

**

P < 0.01

***

P < 0.001

****

P < 0.0001

WT (Sham= 18–23, CLP= 26–33), TLR3−/− (Sham= 5–6, CLP= 5–6), TLR4−/− (Sham= 4–5, CLP= 4–5), TLR2−/− (Sham= 6, CLP= 5–6), TLR7−/− (Sham= 7–11, CLP= 7–12), MyD88−/− (Sham= 7–8, CLP= 8–12), and Trif−/− (Sham= 4, CLP= 6)

CLP = cecal ligation and puncture, MCF = maximum clot firmness, TLR = Toll-like receptor.